1. Home
  2. MSBI vs EYPT Comparison

MSBI vs EYPT Comparison

Compare MSBI & EYPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MSBI
  • EYPT
  • Stock Information
  • Founded
  • MSBI 1881
  • EYPT 1987
  • Country
  • MSBI United States
  • EYPT United States
  • Employees
  • MSBI N/A
  • EYPT N/A
  • Industry
  • MSBI Major Banks
  • EYPT Biotechnology: Laboratory Analytical Instruments
  • Sector
  • MSBI Finance
  • EYPT Industrials
  • Exchange
  • MSBI Nasdaq
  • EYPT Nasdaq
  • Market Cap
  • MSBI 437.3M
  • EYPT 427.9M
  • IPO Year
  • MSBI 2016
  • EYPT 2005
  • Fundamental
  • Price
  • MSBI $18.23
  • EYPT $7.35
  • Analyst Decision
  • MSBI Hold
  • EYPT Strong Buy
  • Analyst Count
  • MSBI 4
  • EYPT 8
  • Target Price
  • MSBI $23.50
  • EYPT $25.71
  • AVG Volume (30 Days)
  • MSBI 106.7K
  • EYPT 752.4K
  • Earning Date
  • MSBI 04-24-2025
  • EYPT 03-05-2025
  • Dividend Yield
  • MSBI 6.73%
  • EYPT N/A
  • EPS Growth
  • MSBI N/A
  • EYPT N/A
  • EPS
  • MSBI N/A
  • EYPT N/A
  • Revenue
  • MSBI $170,129,000.00
  • EYPT $43,273,000.00
  • Revenue This Year
  • MSBI $78.22
  • EYPT N/A
  • Revenue Next Year
  • MSBI $3.38
  • EYPT N/A
  • P/E Ratio
  • MSBI N/A
  • EYPT N/A
  • Revenue Growth
  • MSBI N/A
  • EYPT N/A
  • 52 Week Low
  • MSBI $18.26
  • EYPT $5.54
  • 52 Week High
  • MSBI $28.08
  • EYPT $23.97
  • Technical
  • Relative Strength Index (RSI)
  • MSBI 29.89
  • EYPT 58.84
  • Support Level
  • MSBI $18.50
  • EYPT $5.54
  • Resistance Level
  • MSBI $19.15
  • EYPT $7.45
  • Average True Range (ATR)
  • MSBI 0.50
  • EYPT 0.56
  • MACD
  • MSBI 0.05
  • EYPT 0.20
  • Stochastic Oscillator
  • MSBI 0.00
  • EYPT 92.35

About MSBI Midland States Bancorp Inc.

Midland States Bancorp Inc is a diversified financial holding company. The company provides a full range of commercial and consumer banking products and services, business equipment financing, merchant credit card services, trust and investment management, and insurance and financial planning services. The Banking segment which generates the majority of the revenue, provides a wide range of financial products and services to consumers and businesses, including commercial, commercial real estate, mortgage and other consumer loan products; commercial equipment financing etc. The Wealth Management segment consists of trust and fiduciary services, brokerage and retirement planning services. The Other segment includes the operating results of the parent company.

About EYPT EyePoint Pharmaceuticals Inc.

EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.

Share on Social Networks: